array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(24) "Idexx Laboratories, Inc."
["slug"]=>
string(31) "52dfe-us-idexx-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62"
["description"]=>
string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities."
["address_street"]=>
string(10) "1 Idexx Dr"
["address_place"]=>
string(9) "Westbrook"
["address_region"]=>
string(5) "Maine"
["founding_date"]=>
string(10) "1983-02-28"
["website_domain"]=>
string(9) "idexx.com"
["website_url"]=>
string(21) "https://www.idexx.com"
["industry_codes"]=>
array(4) {
[0]=>
string(43) "General Livestock, Except Dairy and Poultry"
[1]=>
string(33) "Veterinary Services for Livestock"
[2]=>
string(27) "Pharmaceutical Preparations"
[3]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
}
["employee_count"]=>
int(710)
["article_count"]=>
int(643)
}
["articles"]=>
array(5) {
[0]=>
array(7) {
["title_en"]=>
string(66) "IDEXX Laboratories shares with significant price gains (€474.70)"
["snippet_en"]=>
string(208) "The shares of IDEXX Laboratories are currently shining on the US stock exchange. The title rose significantly in price on Monday. An increase of 7.01 percent - with this increase in value the security belongs"
["url"]=>
string(134) "https://www.finanznachrichten.de/nachrichten-2023-12/60833089-idexx-laboratories-aktie-mit-deutlichen-kursgewinnen-474-70-euro-013.htm"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d8883a32-e80e-45be-9f29-5700ab7e39ed"
["source"]=>
string(20) "finanznachrichten.de"
["publication_date"]=>
string(10) "2023-12-04"
["categories"]=>
array(6) {
[0]=>
string(16) "Share Repurchase"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(12) "Going Public"
[3]=>
string(14) "Issuing Shares"
[4]=>
string(12) "Stock Market"
[5]=>
string(15) "Market Movement"
}
}
[1]=>
array(7) {
["title_en"]=>
string(77) "IDEXX Laboratories shares hold up well today: share value rises (€398.7669)"
["snippet_en"]=>
string(190) "The shares of IDEXX Laboratories are currently trading somewhat more firmly on the US stock exchange. Most recently, investors paid $426.86 for the paper. Shareholders can currently be happy"
["url"]=>
string(146) "https://www.finanznachrichten.de/nachrichten-2023-11/60605515-idexx-laboratories-aktie-heute-gut-behauptet-aktienwert-steigt-398-7669-euro-013.htm"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/7595e4d2-08b6-45b3-ad5e-99f39afa1c34"
["source"]=>
string(20) "finanznachrichten.de"
["publication_date"]=>
string(10) "2023-11-08"
["categories"]=>
array(9) {
[0]=>
string(16) "Share Repurchase"
[1]=>
string(9) "Investors"
[2]=>
string(24) "Stock Research & Ratings"
[3]=>
string(21) "Shareholders Feedback"
[4]=>
string(12) "Going Public"
[5]=>
string(14) "Issuing Shares"
[6]=>
string(12) "Stock Market"
[7]=>
string(18) "General Investment"
[8]=>
string(15) "Market Movement"
}
}
[2]=>
array(7) {
["title_en"]=>
string(83) "[IPO magnifying glass] Bionote, employees struggling with overvaluation controversy"
["snippet_en"]=>
string(621) "Bionote, an in vitro diagnostic medical device company, is promoting an initial public offering (IPO) to list on the domestic stock market. Amid criticisms of overvaluation of the scope of the public offering price, the concerns of employees who need to receive employee shares are growing. According to the Electronic Disclosure System of the Financial Supervisory Service on the 25th, Bionote suggested a range of hope for public offering price at 18,000 to 22,000 won. The projected market capitalization is between 1.87 trillion won and 2.287 trillion won. NH Investment & Securities and Korea Investment & Securities"
["url"]=>
string(50) "http://www.asiae.co.kr/article/2022102508572462198"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8affe019-fc5d-4d00-b043-46b04bb19fa6"
["source"]=>
string(11) "asiae.co.kr"
["publication_date"]=>
string(10) "2022-10-25"
["categories"]=>
array(1) {
[0]=>
string(12) "Going Public"
}
}
[3]=>
array(7) {
["title_en"]=>
string(100) "Idexx Stock Clears Key Benchmark Amid Strong Profit, Sales Growth; Expands Via Cloud Software Buyout"
["snippet_en"]=>
string(106) "Follow these 2 basic rules to get in early - and with less risk - on the best IPO stocks to buy and watch."
["url"]=>
string(108) "https://www.investors.com/news/technology/idexx-laboratories-clears-key-benchmark-hitting-80-plus-rs-rating/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/519d1bd4-9039-410c-990c-35e4936563e7"
["source"]=>
string(13) "investors.com"
["publication_date"]=>
string(10) "2021-06-12"
["categories"]=>
array(4) {
[0]=>
string(12) "Stock Market"
[1]=>
string(18) "Expansion & Growth"
[2]=>
string(24) "Quarterly/Annual Figures"
[3]=>
string(12) "Going Public"
}
}
[4]=>
array(7) {
["title_en"]=>
string(63) "IDEXX LABORATORIES STOCK PRICE PREDICTION 2023, 2024, 2025-2027"
["snippet_en"]=>
string(234) "IDEXX Laboratories stock price prediction. IDEXX Laboratories stock forecast for 2023, 2024, 2025, 2026 and 2027 Open, maximum and minimum, close and average prices for each month. IDEXX Laboratories share outlook for near years. IDXX"
["url"]=>
string(30) "https://longforecast.com/idexx"
["image_url"]=>
NULL
["source"]=>
string(16) "longforecast.com"
["publication_date"]=>
string(10) "2012-09-01"
["categories"]=>
array(7) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(21) "Competitive Behaviour"
[2]=>
string(12) "Going Public"
[3]=>
string(12) "Stock Market"
[4]=>
string(18) "General Investment"
[5]=>
string(15) "Market Movement"
[6]=>
string(17) "Commodity Pricing"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(118)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(66)
}
[2]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(44)
}
[3]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(43)
}
[4]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(40)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(25)
}
[6]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(22)
}
[8]=>
array(2) {
["name"]=>
string(12) "Restatements"
["count"]=>
int(21)
}
[9]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(18)
}
[11]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[12]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(12)
}
[14]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[15]=>
array(2) {
["name"]=>
string(9) "Investors"
["count"]=>
int(9)
}
[16]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(8)
}
[17]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(8)
}
[18]=>
array(2) {
["name"]=>
string(31) "Water and Wastewater Management"
["count"]=>
int(7)
}
[19]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(5)
}
}
}
52dfe-us-idexx-laboratories-inc
Idexx Laboratories, Inc.
Location
Maine
Founded
1983-02-28
Website
https://www.idexx.com
Articles
643 Articles
Category
General Livestock, Except Dairy and Poultry
Veterinary Services for Livestock
Pharmaceutical Preparations
In Vitro and In Vivo Diagnostic Substances
Description
10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.
The shares of IDEXX Laboratories are currently shining on the US stock exchange. The title rose significantly in price on Monday. An increase of 7.01 percent - with this increase in value the security belongs
The shares of IDEXX Laboratories are currently trading somewhat more firmly on the US stock exchange. Most recently, investors paid $426.86 for the paper. Shareholders can currently be happy
Bionote, an in vitro diagnostic medical device company, is promoting an initial public offering (IPO) to list on the domestic stock market. Amid criticisms of overvaluation of the scope of the public offering price, the concerns of employees who need to receive employee shares are growing. According to the Electronic Disclosure System of the Financial Supervisory Service on the 25th, Bionote suggested a range of hope for public offering price at 18,000 to 22,000 won. The projected market capitalization is between 1.87 trillion won and 2.287 trillion won. NH Investment & Securities and Korea Investment & Securities
IDEXX Laboratories stock price prediction. IDEXX Laboratories stock forecast for 2023, 2024, 2025, 2026 and 2027 Open, maximum and minimum, close and average prices for each month. IDEXX Laboratories share outlook for near years. IDXX
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
![[IPO magnifying glass] Bionote, employees struggling with overvaluation controversy](https://images.businessradar.com/articles/8affe019-fc5d-4d00-b043-46b04bb19fa6)
